The device, which was recently approved by the FDA, uses pulsed electric fields to efficiently and safely treat A-fib, according to a Nov. 19 press release.
The procedure was successfully performed on Sept. 9 at Northside Hospital Atlanta by cardiac electrophysiologist Alok Gambhir, MD.
Unlike traditional ablation technologies that rely on heat and risk damaging surrounding tissues, Medtronic’s non-thermal mechanism reduces the potential for collateral damage.
Atrial fibrillation currently impacts 59 million people worldwide, and can worsen overtime without early intervention.
